E-LIB Suche - Ergebnisse für: Dering, Judy

1

Clinical evaluation of BCL-2/XL levels pre- and post- HER2-..:

Zoeller, Jason J. ; Press, Michael F. ; Selfors, Laura M....
PLOS ONE. 16 (2021) 5 - p. e0251163 , 2021

Link: https://doi.org/10.1371/..

2

Pathologic and molecular responses to neoadjuvant trastuzum..:

Hurvitz, Sara A. ; Caswell-Jin, Jennifer L. ; McNamara, Katherine L....
Nature Communications. 11 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

3

P1.05-003 Coexpression of CD8a and PD-L1 Frequently Observe..:

Lisberg, Aaron ; Mckenna, Robert ; Dering, Judy...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S614-S615 , 2017

Link: https://doi.org/10.1016/..

4

P2.01-078 Frequent High TIM-3 (HAVCR2) Expression in Resect..:

Lisberg, Aaron ; Mckenna, Robert ; Dering, Judy...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S835 , 2017

Link: https://doi.org/10.1016/..

5

Molecular classification of high grade endometrioid and cle..:

Winterhoff, Boris ; Hamidi, Habib ; Wang, Chen...
Gynecologic Oncology. 141 (2016) 1 - p. 95-100 , 2016

Link: https://doi.org/10.1016/..

6

In vitro activity of the mTOR inhibitor everolimus, in a la..:

Hurvitz, Sara A. ; Kalous, Ondrej ; Conklin, Dylan...
Breast Cancer Research and Treatment. 149 (2015) 3 - p. 669-680 , 2015

Link: https://doi.org/10.1007/..

7

POSTN/TGFBI-associated stromal signature predicts poor prog..:

Karlan, Beth Y. ; Dering, Judy ; Walsh, Christine...
Gynecologic Oncology. 132 (2014) 2 - p. 334-342 , 2014

Link: https://doi.org/10.1016/..

8

Prognostic and Therapeutic Relevance of Molecular Subtypes ..:

Konecny, Gottfried E. ; Wang, Chen ; Hamidi, Habib...
JNCI: Journal of the National Cancer Institute. 106 (2014) 10 - p. , 2014

Link: https://doi.org/10.1093/..

9

AMG 900, pan-Aurora kinase inhibitor, preferentially inhibi..:

Kalous, Ondrej ; Conklin, Dylan ; Desai, Amrita J....
Breast Cancer Research and Treatment. 141 (2013) 3 - p. 397-408 , 2013

Link: https://doi.org/10.1007/..

10

Molecular subtype and response to dasatinib, an Src/Abl sma..:

Finn, Richard S. ; Aleshin, Alexey ; Dering, Judy...
Hepatology. 57 (2013) 5 - p. 1838-1846 , 2013

Link: https://doi.org/10.1002/..

11

Knockdown of ovarian cancer amplification target ADRM1 lead..:

Fejzo, Marlena S. ; Ginther, Chuck ; Dering, Judy...
Genes, Chromosomes and Cancer. 50 (2011) 6 - p. 434-441 , 2011

Link: https://doi.org/10.1002/..

12

Periostin promotes ovarian cancer angiogenesis and metastas..:

Zhu, Min ; Fejzo, Marlena S. ; Anderson, Lee...
Gynecologic Oncology. 119 (2010) 2 - p. 337-344 , 2010

Link: https://doi.org/10.1016/..

13

Cyclin D1 is a direct target of JAG1-mediated Notch signali..:

Cohen, Brenda ; Shimizu, Mamiko ; Izrailit, Julia...
Breast Cancer Research and Treatment. 123 (2009) 1 - p. 113-124 , 2009

Link: https://doi.org/10.1007/..

14

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, pref..:

Finn, Richard S ; Dering, Judy ; Conklin, Dylan...
Breast Cancer Research. 11 (2009) 5 - p. , 2009

Link: https://doi.org/10.1186/..

15

Comprehensive analysis of 20q13 genes in ovarian cancer ide..:

Fejzo, Marlena S. ; Dering, Judy ; Ginther, Chuck...
Genes, Chromosomes and Cancer. 47 (2008) 10 - p. 873-883 , 2008

Link: https://doi.org/10.1002/..